HealthEquity, Inc. (HQY) Stock Analysis
Range Bound setup
Healthcare · Health Information Services
Hold if already holding. Not a fresh buy at $80.51, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -3.4%/30d (confirmed downtrend).
HealthEquity is the largest HSA provider by account count, administering 10.6 million HSAs with $36.5B in assets and 7.2M complementary CDBs as of January 31, 2026. Revenue comes from service fees, custodial fees from insurance company partners and Depository Partners (48% of... Read more
Hold if already holding. Not a fresh buy at $80.51, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -3.4%/30d (confirmed downtrend). Chart setup: RSI 55 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Score 6.0/10, moderate confidence.
Passes 6/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 33d clear, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMProductcustodial revenue from insurance company partners and Depository Partners48%10-K Item 1A: 'fees we earn from our insurance company partners and Depository Partners which comprised approximately 48%, 45%, and 39% of our revenues during the fiscal years ended January 31, 2026, 2025, and 2024'
Material Events(8-K, last 90d)
- 2026-04-06Item 5.02MEDIUMCTO Eli Rosner terminated without cause, effective April 17, 2026. Sunil Rajasekar (EVP, Chief Product & Strategy Officer since Jan 2026) to oversee technology organization. No separate CTO successor named.SEC filing →
- 2026-03-30Item 5.02LOWWilliam Gassen (CEO of Sanford Health) appointed to Board, effective immediately. Board expanded from 9 to 10 members. Will serve on Audit and Risk Committee and TCCC.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $80.51, but acceptable to hold if already in. Reasons: Negative momentum; Below 200-MA, MA slope -3.4%/30d (confirmed downtrend). Chart setup: RSI 55 mid-range, Bollinger mid-band. Maintain position. Not compelling to add more. Target $101.59 (+26.2%), stop $74.96 (−7.4%), A.R:R 3.3:1. Score 6.0/10, moderate confidence.
Take-profit target: $101.59 (+26.0% upside). Target $101.59 (+26.2%), stop $74.96 (−7.4%), A.R:R 3.3:1. Stop-loss: $74.96.
Negative momentum; Below 200-MA, MA slope -3.4%/30d (confirmed downtrend).
HealthEquity, Inc. trades at a P/E of 33.1 (forward 15.3). TrendMatrix value score: 6.4/10. Verdict: Hold.
20 analysts cover HQY with a consensus score of 4.2/5. Average price target: $113.
What does HealthEquity, Inc. do?HealthEquity is the largest HSA provider by account count, administering 10.6 million HSAs with $36.5B in assets and...
HealthEquity is the largest HSA provider by account count, administering 10.6 million HSAs with $36.5B in assets and 7.2M complementary CDBs as of January 31, 2026. Revenue comes from service fees, custodial fees from insurance company partners and Depository Partners (48% of FY2026 revenue), and interchange fees (15%).